Colorectal liver metastases on gadoxetic acid-enhanced MRI: Typical characteristics decrease after chemotherapy

被引:0
作者
van der Reijd, Denise J. [1 ,2 ]
Soykan, Ezgi A. [1 ,3 ]
Heeres, Birthe C. [1 ]
Lambregts, Doenja M. J. [1 ,2 ]
Vollebergh, Marieke A. [4 ]
Kuhlmann, Koert F. D. [5 ]
Kok, Niels F. M. [5 ]
Snaebjornsson, Petur [6 ,7 ]
Beets-Tan, Regina G. H. [1 ,8 ]
Maas, Monique [1 ,2 ]
Klompenhouwer, Elisabeth G. [1 ]
机构
[1] Antoni van Leeuwenhoek Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands
[2] Maastricht Univ, GROW Sch Oncol & Reprod, Maastricht, Netherlands
[3] Univ Amsterdam, Canc Ctr Amsterdam, Dept Radiol & Nucl Med, Amsterdam UMC, Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Netherlands Canc Inst, Dept Gastrointestinal Oncol, Amsterdam, Netherlands
[5] Antoni van Leeuwenhoek Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
[6] Antoni van Leeuwenhoek Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
[7] Univ Iceland, Fac Med, Reykjavik, Iceland
[8] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark
关键词
Magnetic resonance imaging; Liver; Colorectal cancer; Metastasis; Gadoxetic acid; Chemotherapy; GD-EOB-DTPA; PERILESIONAL ENHANCEMENT; HEPATIC METASTASES; CT; ACCURACY; IMPACT;
D O I
10.1016/j.clinimag.2025.110417
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To determine to what extent colorectal liver metastases (CRLM) display typical imaging characteristics on gadoxetic acid-enhanced magnetic resonance imaging (MRI) and what changes after chemotherapy. Methods: We retrospectively identified 258 patients with a gadoxetic acid-enhanced MRI between 2015 and 2021 and pathologically proven non-mucinous adenocarcinoma CRLM. 722 unique CRLMs were analyzed: 378 CRLM in only the chemotherapy-na & iuml;ve analysis; 217 in post-chemotherapy analysis; and 127 CRLM were analyzed both pre- and post-chemotherapy. The following six characteristics were defined as typical; "hypovascular", "unenhanced T1-weighted (UE-T1W) hypointensity", "arterial rim enhancement", "non-enhancing during hepatobiliary phase", "T2-weighted (T2W) mild hyperintensity", and "diffusion restriction". Results: All six typical characteristics were found in 249/505 chemotherapy-na & iuml;ve CRLM (49 %) and 87/344 post- chemotherapy CRLM (25 %). The occurrence of some typical characteristics decreased post-chemotherapy: UET1W hypointensity 485/505 (96 %) versus 311/336 (93 %), arterial rim enhancement 291/498 (58 %) versus 154/301 (51 %), T2W mild hyperintensity 478/505 (95 %) versus 269/338 (79 %), and diffusion restriction 435/497 (87 %) versus 200/306 (65 %). Almost all metastases showed a hypovascular appearance, both in the chemotherapy-na & iuml;ve (495/504, 98 %) and post-chemotherapy group (330/331, 100 %). Additionally, all CRLM appeared non-enhancing compared to the liver in the hepatobiliary phase (100 %). Conclusion: Most CRLM show various combinations of at least five typical characteristics on gadoxetic acid- enhanced MRI. Arterial rim enhancement is the least prevalent characteristic both in chemotherapy-na & iuml;ve and post-chemotherapy patients. Post-chemotherapy the occurrence of typical MRI characteristics decreases, especially mild T2W hyperintensity and the presence of diffusion restriction.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Quantification of liver function using gadoxetic acid-enhanced MRI
    Sarah Poetter-Lang
    Nina Bastati
    Alina Messner
    Antonia Kristic
    Alexander Herold
    Jacqueline C. Hodge
    Ahmed Ba-Ssalamah
    Abdominal Radiology, 2020, 45 : 3532 - 3544
  • [32] Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases
    Peter Bannas
    Candice A. Bookwalter
    Tim Ziemlewicz
    Utaroh Motosugi
    Alejandro Munoz del Rio
    Theodora A. Potretzke
    Scott K. Nagle
    Scott B. Reeder
    European Radiology, 2017, 27 : 32 - 40
  • [33] A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases
    Vilgrain, Valerie
    Esvan, Maxime
    Ronot, Maxime
    Caumont-Prim, Aurore
    Aube, Christophe
    Chatellier, Gilles
    EUROPEAN RADIOLOGY, 2016, 26 (12) : 4595 - 4615
  • [34] Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI
    Young Kon Kim
    Young Hwan Lee
    Chong Soo Kim
    Min Woo Lee
    Abdominal Imaging, 2011, 36
  • [35] Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI
    Stefano Palmucci
    World Journal of Hepatology, 2014, (07) : 477 - 485
  • [36] Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases
    Mulder, B. G. Sibinga
    Visser, K.
    Feshtali, S.
    Vahrmeijer, A. L.
    Swijnenburg, R. J.
    Hartgrink, H. H.
    van den Boom, R.
    Burgmans, M. C.
    Mieog, J. S. D.
    BMC MEDICAL IMAGING, 2018, 18
  • [37] Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases
    Shin, Na-Young
    Kim, Myeong-Jin
    Lim, Joon Seok
    Park, Mi-Suk
    Chung, Yong-Eun
    Choi, Jin-Young
    Kim, Ki Whang
    Park, Young-Nyun
    EUROPEAN RADIOLOGY, 2012, 22 (04) : 864 - 871
  • [38] The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer
    Choi, Seo-Youn
    Kim, Young Kon
    Min, Ji Hye
    Cha, Dong Ik
    Jeong, Woo Kyoung
    Lee, Won Jae
    EUROPEAN RADIOLOGY, 2017, 27 (10) : 4383 - 4393
  • [39] Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?
    Steffen, Ingo G.
    Weissmann, Thomas
    Rothe, Jan Holger
    Geisel, Dominik
    Chopra, Sascha S.
    Kahn, Johannes
    Hamm, Bernd
    Denecke, Timm
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 12
  • [40] Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy
    Hooman Hosseini-Nik
    Sandra E. Fischer
    Carol-Anne E. Moulton
    Gautam Karbhase
    Ravi J. Menezes
    Steven Gallinger
    Kartik S. Jhaveri
    Abdominal Radiology, 2016, 41 : 231 - 238